ATE513908T1 - Antiangiogenische polypeptide und verfahren zur angiogenesehemmung - Google Patents
Antiangiogenische polypeptide und verfahren zur angiogenesehemmungInfo
- Publication number
- ATE513908T1 ATE513908T1 AT05106596T AT05106596T ATE513908T1 AT E513908 T1 ATE513908 T1 AT E513908T1 AT 05106596 T AT05106596 T AT 05106596T AT 05106596 T AT05106596 T AT 05106596T AT E513908 T1 ATE513908 T1 AT E513908T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibiting angiogenesis
- antiangiogenic polypeptides
- antiangiogenic
- polypeptides
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/643,219 US5801146A (en) | 1996-05-03 | 1996-05-03 | Compound and method for inhibiting angiogenesis |
US08/832,087 US5981484A (en) | 1996-05-03 | 1997-04-03 | Antiangiogenic peptides and methods for inhibiting angiogenesis |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE513908T1 true ATE513908T1 (de) | 2011-07-15 |
Family
ID=24579877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05106596T ATE513908T1 (de) | 1996-05-03 | 1997-05-05 | Antiangiogenische polypeptide und verfahren zur angiogenesehemmung |
Country Status (8)
Country | Link |
---|---|
US (2) | US5801146A (de) |
JP (1) | JP4722989B2 (de) |
AT (1) | ATE513908T1 (de) |
CA (1) | CA2253243C (de) |
CZ (1) | CZ300141B6 (de) |
ES (1) | ES2367307T3 (de) |
HK (1) | HK1082762A1 (de) |
IL (2) | IL126626A (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5945403A (en) * | 1997-05-30 | 1999-08-31 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
US5837682A (en) * | 1996-03-08 | 1998-11-17 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
US20020031518A1 (en) * | 1996-10-09 | 2002-03-14 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Plasminogen fragment having activity to inhibit tumor metastasis and growth and process for preparing same technical field |
CA2318578A1 (en) * | 1998-01-20 | 1999-07-22 | Abbott Laboratories | Specific antibodies to kringle 5 of apoliprotein a and methods of use therefor |
WO2000003726A1 (en) * | 1998-07-14 | 2000-01-27 | Bristol-Myers Squibb Company | Lysine binding fragments of angiostatin |
US7317003B2 (en) * | 1998-09-04 | 2008-01-08 | National University Of Singapore | Small peptides having anti-angiogenic and endothelial cell inhibition activity |
US6465424B1 (en) | 1999-02-17 | 2002-10-15 | Bristol-Myers Squibb Company | Anti-angiogenic agent and method for inhibiting angiogenesis |
CA2501421A1 (en) * | 1999-05-17 | 2000-11-23 | Conjuchem Inc. | Long lasting exendin-4 |
US7144854B1 (en) | 1999-09-10 | 2006-12-05 | Conjuchem, Inc. | Long lasting anti-angiogenic peptides |
US6576610B1 (en) | 1999-10-04 | 2003-06-10 | Nuvas, Llc | Use of a context-dependent functional entity to enhance the efficacy of an agent |
CA2394167A1 (en) * | 1999-12-15 | 2001-06-21 | Entremed, Inc. | Compositions and methods for inhibiting endothelial cell proliferation |
FR2803207B1 (fr) * | 1999-12-30 | 2004-04-30 | Aventis Pharma Sa | Utilisation d'un vecteur comprenant un acide nucleique codant pour un facteur anti-angiogenique pour le traitement des neovascularisations corneennes |
ATE303820T1 (de) * | 1999-12-30 | 2005-09-15 | Aventis Pharma Sa | Verwendung von einem für einem anti-angiogenen faktor codierenden vektor zur behandlung von vaskularisation der hornhaut |
DK1299727T3 (da) | 2000-07-12 | 2009-06-15 | Agensys Inc | Hidtil ukendt tumorantigen, der er egnet til diagnosticering og behandling af blære-, ovarie-, lunge-, og nyrecancertyper |
AU2001285919B2 (en) | 2000-09-05 | 2007-08-23 | Jiangsu Simcere Pharmaceutical R&D Co., Ltd | Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
US20020159992A1 (en) * | 2000-09-29 | 2002-10-31 | Jack Henkin | Antiangiogenic polypeptides and methods for inhibiting angiogenesis |
AU2002239414A1 (en) * | 2000-11-02 | 2002-05-27 | Bristol-Myers Squibb Company | Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors |
US20040121945A1 (en) * | 2000-12-15 | 2004-06-24 | Hong Liang | Compositions and methods for inhibiting endothelial cell proliferation |
GB0122318D0 (en) * | 2001-09-14 | 2001-11-07 | Novartis Ag | Organic compounds |
US20030211519A1 (en) * | 2001-12-19 | 2003-11-13 | Davidson Donald J. | Uses of an endothelial cell receptor |
US6818420B2 (en) * | 2002-02-27 | 2004-11-16 | Biosource International, Inc. | Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same |
US7285277B2 (en) * | 2002-03-15 | 2007-10-23 | Mogam Biotechnology Research Institute | Anticancer agent |
US20040121955A1 (en) * | 2002-04-01 | 2004-06-24 | Mulligan-Kehoe Mary Jo | Methods for modulating angiogenesis |
US20050053993A1 (en) * | 2002-12-18 | 2005-03-10 | Davidson Donald J. | Uses of an endothelial cell receptor |
US20050250694A1 (en) * | 2003-10-10 | 2005-11-10 | Ma Jian-Xing | Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same |
WO2007035678A2 (en) * | 2005-09-19 | 2007-03-29 | The University Of Chicago | Methods of identifying agents having antiangiogenic activity |
CN101356629B (zh) * | 2005-11-09 | 2012-06-06 | 高级技术材料公司 | 用于将其上具有低k介电材料的半导体晶片再循环的组合物和方法 |
US8933031B2 (en) * | 2008-02-04 | 2015-01-13 | Shanghai First People's Hospital | Polypeptide inhibiting angiogenesis and application thereof |
JP5819293B2 (ja) * | 2009-07-10 | 2015-11-24 | スロンボジェニックス・ナムローゼ・フェンノートシャップThromboGenics NV | プラスミノーゲンおよびプラスミンの変異体 |
CN101974505A (zh) * | 2010-09-30 | 2011-02-16 | 西北大学 | 一种表达高活性可溶型血管生长抑制剂Kringle5三聚体工程菌的高密度发酵方法及其相应蛋白的分离纯化方法 |
WO2022037687A1 (zh) * | 2020-08-20 | 2022-02-24 | 泰伦基国际有限公司 | 一种治疗肿瘤的方法和药物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9019120D0 (en) * | 1990-09-01 | 1990-10-17 | Beecham Group Plc | Novel compounds |
US5512591A (en) * | 1993-02-18 | 1996-04-30 | President And Fellows Of Harvard College | Treatments for diseases characterized by neovascularization |
US5469431A (en) * | 1993-07-12 | 1995-11-21 | Philips Electronics North America Corp. | Method of and apparatus for channel mapping with relative service identification |
US5639725A (en) * | 1994-04-26 | 1997-06-17 | Children's Hospital Medical Center Corp. | Angiostatin protein |
CA2188813C (en) * | 1994-04-26 | 2010-08-03 | Michael S. O'reilly | Angiostatin protein, nucleic acids encoding the same and methods of detection |
NZ330537A (en) * | 1995-12-13 | 2001-06-29 | Childrens Medical Center | Kringle 5 rerion of plasminogen as an endothelial cell proliferation inhibitor |
US5854221A (en) * | 1996-12-12 | 1998-12-29 | The Children's Medical Center Corporation | Endothelial cell proliferation inhibitor and method of use |
-
1996
- 1996-05-03 US US08/643,219 patent/US5801146A/en not_active Expired - Lifetime
-
1997
- 1997-04-03 US US08/832,087 patent/US5981484A/en not_active Expired - Lifetime
- 1997-05-05 CZ CZ20060013A patent/CZ300141B6/cs not_active IP Right Cessation
- 1997-05-05 AT AT05106596T patent/ATE513908T1/de not_active IP Right Cessation
- 1997-05-05 CA CA2253243A patent/CA2253243C/en not_active Expired - Fee Related
- 1997-05-05 ES ES05106596T patent/ES2367307T3/es not_active Expired - Lifetime
-
1998
- 1998-10-16 IL IL126626A patent/IL126626A/en not_active IP Right Cessation
-
1999
- 1999-10-27 HK HK06100885.2A patent/HK1082762A1/xx not_active IP Right Cessation
-
2008
- 2008-11-13 JP JP2008290560A patent/JP4722989B2/ja not_active Expired - Fee Related
- 2008-12-09 IL IL195827A patent/IL195827A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2253243C (en) | 2010-04-06 |
CA2253243A1 (en) | 1997-11-13 |
JP4722989B2 (ja) | 2011-07-13 |
IL126626A (en) | 2009-12-24 |
HK1082762A1 (en) | 2006-06-16 |
US5981484A (en) | 1999-11-09 |
CZ300141B6 (cs) | 2009-02-18 |
IL195827A0 (en) | 2011-08-01 |
IL195827A (en) | 2014-03-31 |
US5801146A (en) | 1998-09-01 |
JP2009106290A (ja) | 2009-05-21 |
ES2367307T3 (es) | 2011-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE513908T1 (de) | Antiangiogenische polypeptide und verfahren zur angiogenesehemmung | |
WO1997041824A3 (en) | Antiangiogenic peptides derived from plasminogen | |
DE4491714T1 (de) | Methoden und Zusammensetzungen zur Kontrolle der Pflanzenentwicklung | |
DE69725169D1 (de) | Zusammensetzungen und verfahren zur anregung des wachstums von neuriten | |
ATA264288A (de) | Verfahren und anlage zur herstellung von fluessigem roheisen | |
DE69431714D1 (de) | Verfahren und zusammensetzung zur verdauung von gewebe | |
DE69726289D1 (de) | Verfahren und zusammensetzung zur behandlung von substraten bezüglich benetzbarkeit | |
DE69723796D1 (de) | Verfahren zur Behandlung von rostfreien Stahlschlacken | |
ID18243A (id) | Metode dan peralatan untuk mengontrol tayangan petunjuk program elektrik | |
NO986202L (no) | FremgangsmÕte for fremstilling av rekombinant adÚnovirus | |
DE3888360D1 (de) | Hochspannungsschalter und verfahren zur ansteuerung von verbrauchern mittels des hochspannungsschalters. | |
BG103286A (en) | Compositions and methods for ore dressing | |
DE69726123D1 (de) | Verfahren zur behandlung von gefässkrankheiten mittels tumornekrosefaktor-antagonisten | |
DE59606475D1 (de) | Verfahren zum Herstellen von legierten Stählen und Elektroofenanlage mit verstellbaren Frischlanzen dafür | |
DE59209268D1 (de) | Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen | |
DE69521433D1 (de) | Neue polyolester von ethercarbonsäuren und verfahren zur faserveredelung | |
DE69626311D1 (de) | Zusammensetzung zur behandlung von wäsche sowie verfahren hierfür | |
DE69633798D1 (de) | Immunogenische zusammensetzung und verfahren zur verbesserung der produktivität von wiederkäuern | |
DE68928639D1 (de) | Verfahren zur regelung der kühlung von stahlmaterial | |
BG98888A (en) | Method for the preparation of 3-acylestratrienes and acylbezenes | |
DE68913509D1 (de) | Verfahren zur Herstellung von flüssigem Roheisen. | |
IL94526A0 (en) | Method for c-terminal modification of proteins | |
DE68924000D1 (de) | Verfahren zur Veredelung der magnetischen Bereiche von elektrischen Stählen. | |
DE69717759D1 (de) | Benzo(6)Thiophen-Verbindungen, Zwischenprodukte, Zusammensetzungen und Verfahren dafür | |
EA199900429A1 (ru) | Синтез бензо[f]хинолинонов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |